课题基金 / 基金详情

项目摘要

项目成果

Shyam S Mohapatra的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):该提案寻求对新教师招聘的支持,以增强南佛罗里达大学医学院纳米医学研究中心(NRC)的研究资源,该中心的使命是作为推进心脏、肺和血液疾病纳米医学基本和转化方面的催化剂。NRC的目标是:(i)开发创新和综合的纳米和细胞技术,(ii)培育和促进这些先进技术从实验室到诊所的过渡,(iii)促进大学-产业和佛罗里达州范围内的纳米医学,组织工程和细胞技术合作。NRC成员(约18人)包括来自文理学院、工程学院、护理医学学院和公共卫生学院的教师。NRC寻求建立一个由生物学家,工程师,科学家和临床医生组成的多学科团队,以协调和集中的方式工作,开发综合技术,以加速将分子和细胞知识转化为医疗和细胞技术的纳米技术应用。NRC位于医学院,并在VA医院和跨学科研究大楼设有卫星实验室。该中心目前有6名核心教师和12名兼职教师和一些支持人员,博士后研究员和研究生。NRC已经确定了两个研究领域的重要性:(i)免疫细胞靶向治疗肺部疾病和(ii)干细胞-血液分化的3-D纳米基质。核管理委员会已经确认玛丽马凯维奇博士,华盛顿大学的讲师,圣刘易斯作为一个潜在的候选人终身教职在核管理委员会。医学院已承诺在完成P-30支助后为这一职位提供薪金和支助人员、设备和用品的启动资金。玛丽Markiwicz博士的基础研究NKG 2D作为一个潜在的免疫调节系统的呼吸道病毒感染追求在NRC是优秀的,预计将提高NRC的纳米医学应用在基础和转化研究。这项支持不仅有望为4名训练有素的个人提供就业机会,而且将显著影响他们的生活和对纳米医学研究的贡献。 该提案寻求支持新的教师招聘,以加强南佛罗里达大学医学院纳米医学研究中心(NRC)的研究资源,其使命是作为一种催化剂,推进基本和转化方面的纳米医学的心,肺和血液疾病。这一支持将为高素质的个人创造四个就业机会。
英文摘要
DESCRIPTION (provided by applicant): This proposal seeks support for new faculty recruitment to enhance research resources for the Nanomedicine Research Center (NRC) at the University of South Florida College of Medicine, whose mission is to serve as a catalyst for advancing the basic and translational aspects nanomedicine for Heart, Lung and Blood disorders. The NRC goals are to: (i) develop innovative and integrative nano- and cell-technologies, (ii) nurture and foster the transition of these advanced technologies from the laboratory to the clinic, (iii) foster university-industry and Florida-wide collaborations in nanomedicine, tissue engineering and cell technologies. The NRC members (about 18) include faculty from the colleges of Arts and Sciences, Engineering, Nursing Medicine and Public Health. The NRC seeks to create a multidisciplinary team of biologists, engineers, scientists and clinicians, working in a coordinated and focused effort, to develop integrated technology to accelerate the translation of molecular and cellular knowledge into nanotechnology applications for medical and cell technologies. The NRC is located at the College of Medicine and has satellite laboratories at the VA Hospital and Interdisciplinary Research Building. The Center currently has 6 core faculty and 12 adjunct faculty and several support staff, postdoctoral fellows and graduate students. The NRC has identified two areas of research for enhancement in order of importance: (i) immune cell-targeted therapeutics for lung diseases and (ii) stem cell-blood differentiation on 3-D nanomatrices. The NRC has identified Mary Markiewicz, PhD, Instructor at Washington Univ., St Louis as a potential candidate for tenure-track faculty at the NRC. The College of Medicine has made a commitment for this position with salary and start-up funding for support personnel, equipment and supplies following the completion of P-30 support. Dr. Mary Markiwicz's basic research on NKG2D as a potential immunomodulatory system for respiratory viral infections pursued at the NRC is excellent and is expected to enhance the NRC's nanomedicine application in basic and translational research. This support is not only expected to provide jobs for 4 highly trained individuals, but will significantly affect their lives and contributions to nanomedicine research. This proposal seeks support for new faculty recruitment to enhance research resources for the Nanomedicine Research Center (NRC) at the University of South Florida College of Medicine, whose mission is to serve as a catalyst for advancing the basic and translational aspects nanomedicine for heart lung and blood disorders. This support will permit creation of four jobs to highly qualified individuals.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3727/096368910x536491
发表时间: 2011
期刊: Cell transplantation
影响因子: 3.3
作者: [Kumar A, Glaum M, El-Badri N, Mohapatra S, Haller E, Park S, Patrick L, Nattkemper L, Vo D, Cameron DF]
通讯作者: Cameron DF
DOI: 10.3390/s130708490
发表时间: 2013-07-03
期刊: Sensors (Basel, Switzerland)
影响因子: --
作者: [Huls NF, Phan MH, Kumar A, Mohapatra S, Mohapatra S, Mukherjee P, Srikanth H]
通讯作者: Srikanth H
CD4(+) T cells suppress immune response to cancer: novel targets for antitumor efforts.
CD4(+) T 细胞抑制对癌症的免疫反应:抗肿瘤工作的新目标。
DOI: 10.1586/eci.12.29
发表时间: 2012
期刊: Expert review of clinical immunology
影响因子: 4.4
作者: [Nelson,Allison, Nair,Sajitha, Nagaraj,Srinivas]
通讯作者: Nagaraj,Srinivas
DOI: 10.1016/j.bbrc.2008.07.051
发表时间: 2008-09-26
期刊: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
影响因子: 3.1
作者: [Shirley, Shawna A., Montpeti, Alison J., Lockey, R. F., Mohapatra, Shyam S.]
通讯作者: Mohapatra, Shyam S.
BLRD Merit Review Research Career Scientist Award
  • 批准号:
    10594022
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2022
  • 负责人:
    Shyam S Mohapatra
  • 依托单位:
Nanomicellar antiviral strategies for RSV infection
  • 批准号:
    10516004
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2017
  • 负责人:
    Shyam S Mohapatra
  • 依托单位:
BLRD Research Career Scientist Award Application
  • 批准号:
    9898309
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2017
  • 负责人:
    Shyam S Mohapatra
  • 依托单位:
BLRD Research Career Scientist Award Application
  • 批准号:
    10265371
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2017
  • 负责人:
    Shyam S Mohapatra
  • 依托单位:
海外基金